PWMG
DNA icon

Prestige Wealth Management Group’s Ginkgo Bioworks DNA Stock Holding History

Prestige Wealth Management Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11
Closed -$532 – 1004
2024
Q1 		$532 Hold
11
– – ﹤0.01% 947
2023
Q4 		$775 Hold
11
– – ﹤0.01% 883
2023
Q3 		$829 Hold
11
– – ﹤0.01% 900
2023
Q2 		$852 Hold
11
– – ﹤0.01% 924
2023
Q1 		$610 Hold
11
– – ﹤0.01% 950
2022
Q4 		$774 Buy
+11
New +$1.01K ﹤0.01% 1014

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Prestige Wealth Management Group's DNA Position: Q2 2024 in Review

Prestige Wealth Management Group sold out of Ginkgo Bioworks (DNA) in Q2 2024, closing a stake of 11 shares — an estimated $532 sold.

Prestige Wealth Management Group first reported a position in DNA in Q4 2022 and held it in 6 quarters. The position peaked at $852 in Q2 2023. 313 funds tracked by Wall St. Rank hold DNA as of Q2 2024.

  • Prestige Wealth Management Group reported no remaining Ginkgo Bioworks position as of Q2 2024 after selling out during the quarter.
  • Prestige Wealth Management Group sold 11 Ginkgo Bioworks shares in Q2 2024, an estimated $532.
  • Prestige Wealth Management Group first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 6 quarters.
  • Prestige Wealth Management Group's Ginkgo Bioworks position peaked at $852 in Q2 2023.
  • 313 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2024.

Based on Prestige Wealth Management Group's 13F filing for Q2 2024, filed 6 Aug 2024.